Shawna Hengel

1.4k total citations
29 papers, 987 citations indexed

About

Shawna Hengel is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shawna Hengel has authored 29 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shawna Hengel's work include Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Proteomics Techniques and Applications (8 papers). Shawna Hengel is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Proteomics Techniques and Applications (8 papers). Shawna Hengel collaborates with scholars based in United States, United Kingdom and Switzerland. Shawna Hengel's co-authors include Errol Robinson, Richard Smith, Erin Baker, Ryan Kelly, Thomas E. Angel, Uma K. Aryal, David R. Goodlett, Ljiljana Paša‐Tolić, Si Wu and John Valliere‐Douglass and has published in prestigious journals such as Chemical Society Reviews, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Shawna Hengel

27 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawna Hengel United States 16 615 374 205 161 99 29 987
Jenny Ottosson Sweden 15 1.2k 2.0× 340 0.9× 115 0.6× 302 1.9× 94 0.9× 31 1.6k
Geneviève Choquet‐Kastylevsky France 19 503 0.8× 289 0.8× 167 0.8× 158 1.0× 189 1.9× 35 1.1k
Jiang Wu United States 20 1.1k 1.8× 762 2.0× 128 0.6× 188 1.2× 145 1.5× 43 1.8k
Kevin D. Smith United Kingdom 21 838 1.4× 205 0.5× 246 1.2× 90 0.6× 91 0.9× 48 1.2k
Gunjan Malik United States 15 620 1.0× 383 1.0× 144 0.7× 69 0.4× 85 0.9× 34 1.0k
Mihaela Antonovici Canada 9 453 0.7× 293 0.8× 62 0.3× 72 0.4× 65 0.7× 9 782
Stephen J. Coales United States 17 647 1.1× 407 1.1× 49 0.2× 131 0.8× 58 0.6× 25 1.1k
Wei Jia China 18 732 1.2× 207 0.6× 99 0.5× 51 0.3× 96 1.0× 71 1.1k
Irene van den Broek Netherlands 18 585 1.0× 509 1.4× 84 0.4× 106 0.7× 166 1.7× 30 1.0k
Hermann Beck Germany 11 766 1.2× 180 0.5× 100 0.5× 431 2.7× 246 2.5× 16 1.0k

Countries citing papers authored by Shawna Hengel

Since Specialization
Citations

This map shows the geographic impact of Shawna Hengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawna Hengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawna Hengel more than expected).

Fields of papers citing papers by Shawna Hengel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawna Hengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawna Hengel. The network helps show where Shawna Hengel may publish in the future.

Co-authorship network of co-authors of Shawna Hengel

This figure shows the co-authorship network connecting the top 25 collaborators of Shawna Hengel. A scholar is included among the top collaborators of Shawna Hengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawna Hengel. Shawna Hengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levengood, Matthew R., Xinqun Zhang, Lori Westendorf, et al.. (2024). Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47. Molecular Cancer Therapeutics. 24(4). 471–484.
4.
Walles, Markus, Michael J. Berna, Wenying Jian, et al.. (2022). A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation. Drug Metabolism and Disposition. 50(6). 846–857. 10 indexed citations
5.
Kulukian, Anita, et al.. (2021). Abstract PS10-08: Tucatinib potentiates the activity of the antibody-drug conjugate T-DM1 in preclinical models of HER2-positive breast cancer. Cancer Research. 81(4_Supplement). PS10–8. 4 indexed citations
6.
Khanh, T., Laura Q.M. Chow, Karen L. Reckamp, et al.. (2021). First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors. The Oncologist. 26(11). 925–e1918. 30 indexed citations
8.
Sanderson, Russell J., Nicole D. Nicholas, Shawna Hengel, et al.. (2015). Antibody-Conjugated Drug Assay for Protease-Cleavable Antibody–Drug Conjugates. Bioanalysis. 8(1). 55–63. 37 indexed citations
9.
Rock, Brooke M., Shawna Hengel, Dan A. Rock, Larry C. Wienkers, & Kent L. Kunze. (2014). Characterization of Ritonavir-Mediated Inactivation of Cytochrome P450 3A4. Molecular Pharmacology. 86(6). 665–674. 71 indexed citations
10.
Valliere‐Douglass, John, et al.. (2014). Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry. Molecular Pharmaceutics. 12(6). 1774–1783. 32 indexed citations
11.
Liu, Xiaowen, Shawna Hengel, Si Wu, et al.. (2013). Identification of Ultramodified Proteins Using Top-Down Tandem Mass Spectra. Journal of Proteome Research. 12(12). 5830–5838. 44 indexed citations
12.
Hengel, Shawna, et al.. (2012). Molecular and Biological Characterization of Streptococcal SpyA-mediated ADP-ribosylation of Intermediate Filament Protein Vimentin. Journal of Biological Chemistry. 287(25). 21481–21491. 28 indexed citations
13.
Tian, Zhixin, Nikola Tolić, Rui Zhao, et al.. (2012). Enhanced top-down characterization of histone post-translational modifications. Genome biology. 13(10). R86–R86. 111 indexed citations
14.
Robinson, Errol, et al.. (2012). FRET Imaging of Diatoms Expressing a Biosilica-Localized Ribose Sensor. PLoS ONE. 7(3). e33771–e33771. 25 indexed citations
15.
Hengel, Shawna, et al.. (2012). Evaluation of SDS depletion using an affinity spin column and IMSMS detection. PROTEOMICS. 12(21). 3138–3142. 25 indexed citations
16.
Angel, Thomas E., Uma K. Aryal, Shawna Hengel, et al.. (2012). Mass spectrometry-based proteomics: existing capabilities and future directions. Chemical Society Reviews. 41(10). 3912–3912. 304 indexed citations
17.
Foss, Eric J., Dragan Radulović, Derek L. Stirewalt, et al.. (2012). Proteomic Classification of Acute Leukemias by Alignment-Based Quantitation of LC–MS/MS Data Sets. Journal of Proteome Research. 11(10). 5005–5010. 20 indexed citations
18.
Hengel, Shawna & David R. Goodlett. (2011). A review of tandem mass spectrometry characterization of adenosine diphosphate-ribosylated peptides. International Journal of Mass Spectrometry. 312. 114–121. 31 indexed citations
19.
Hengel, Shawna, Euan Murray, Simon P. Langdon, et al.. (2011). Data-independent Proteomic Screen Identifies Novel Tamoxifen Agonist that Mediates Drug Resistance. Journal of Proteome Research. 10(10). 4567–4578. 40 indexed citations
20.
Carrasco, Michael R., et al.. (2002). Synthesis of neoglycopeptides by chemoselective reaction of carbohydrates with peptides containing a novel N′-methyl-aminooxy amino acid. Tetrahedron Letters. 43(33). 5727–5729. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026